Sept 18 (Reuters) - Energy Capital Partners-backed ProEnergy is seeking a valuation of as much as $50 billion in a US initial public offering, Bloomberg News reported on Friday, citing people ...
A drug used to treat erectile dysfunction and enlarged prostate symptoms may raise the risk of glaucoma, a serious eye condition that can cause gradual vision loss, according to new research. An ...
ABSTRACT: Background: Glaucoma is the leading cause of irreversible blindness globally, and reducing intraocular pressure (IOP) is the only evidence-based therapeutic strategy. Minimally invasive ...
ABSTRACT: Background: Glaucoma is the leading cause of irreversible blindness globally, and reducing intraocular pressure (IOP) is the only evidence-based therapeutic strategy. Minimally invasive ...
Joshua Broadwater, DVM, DACVO, at Fetch Charlotte shares more on glaucoma treatment, including laser techniques, in this interview with dvm360. How do you choose the best surgical path for a primary ...
ST. LOUIS, March 03, 2026--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation's leading provider of clinically integrated, doctor-led eye care, today released its 2025 Quality and Outcomes Report, ...
PANAMA CITY, Fla. (WJHG/WECP) - Northwest Florida Beaches International Airport set a new passenger record in 2025, with nearly 1.93 million travelers passing through the airport, officials said. The ...
MILWAUKEE, December 08, 2025--(BUSINESS WIRE)--ECP, the leading software platform purpose-built for assisted living, announced today a significant growth investment from software specialist Level ...
Synergy ECP, a software engineering, cybersecurity and systems engineering services provider, has acquired NetServices, a company offering secure, mission-focused technology services. The Columbia, ...
(PRESS RELEASE) WALTHAM, MA — BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, announced that it has received 510(k) ...
BVI Medical announced that it received FDA 510(k) clearance for its Leos (laser endoscopy ophthalmic system) for treating glaucoma. Waltham, Massachusetts–based BVI designed Leos for a more intuitive ...
This clearance marks a significant advancement in glaucoma care, especially for earlier stages of the disease and across a wide spectrum of glaucoma types. This novel, proprietary laser-based system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results